Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Clin Microbiol Infect ; 23(1): 38-45, 2017 Jan.
Article in English | MEDLINE | ID: mdl-27720865

ABSTRACT

OBJECTIVES: Cytomegalovirus (CMV) reactivation in intensive care unit patients may increase mortality and favour bacterial pneumonia. We developed a murine model to compare the severity of staphylococcal pneumonia after CMV reactivation and in CMV-negative mice. METHODS: Balb/c mice were primo-infected with murine cytomegalovirus (MCMV n=90) or received saline (control n=90). After latency, all mice underwent caecal ligation and puncture to trigger MCMV reactivation in MCMV primary-infected mice. Surviving animals received an intra-nasal inoculation with methicillin-susceptible Staphylococcus aureus (MSSA) to induce pneumonia. Mortality, lung bacterial count, histology and interferon-alpha and gamma serum levels were compared in MCMV reactivated and control mice 2, 5 and 15 days after pneumonia. RESULTS: After MSSA pneumonia, MCMV mice showed a trend towards a higher mortality (9.4% versus 0%; p 0.09) and a higher weight loss (2.2 (0.6-4.1 g) versus 0.7 (-0.3 to 1.3 g); p 0.005). The lung bacterial count was higher in MCMV mice 2 days (5×103 (103 to 3×105) versus 102 (0 to 4×102) CFU/lung; p 0.007) and 5 days (2.5×104 (1.6×104 to 6.5×105) versus 15 (10-40) CFU/lung; p 0.005) after MSSA pneumonia. 8/40 (20%) MCMV mice developed lung abscesses compared to 0% in control (p 0.011). Interferon-alpha serum levels 2 days after staphylococcal pneumonia were higher in MCMV mice. CONCLUSIONS: MCMV reactivation decreased lung bacterial clearance and favoured the development of staphylococcal abscessing pneumonia. CMV reactivation may be responsible for a higher susceptibility to bacterial sepsis.


Subject(s)
Cytomegalovirus Infections/complications , Pneumonia, Bacterial/microbiology , Staphylococcal Infections/microbiology , Staphylococcus aureus/pathogenicity , Virus Activation , Animals , Coinfection , Mice , Pneumonia, Bacterial/complications , Virulence
2.
J Virol Methods ; 187(2): 234-7, 2013 Feb.
Article in English | MEDLINE | ID: mdl-23117065

ABSTRACT

As a partner of the European Virus Archive (EVA) FP7 infrastructure, our research group is maintaining and developing a large virus collection. To meet the standards of the quality management system adopted by all European Virus Archive partners, the detection and eradication of mycoplasma in cell culture supernatants (stored at -80°C or freeze-dried) has to be improved. Although the methods for mycoplasma elimination from infected cell lines were largely described, the decontamination procedures of precious cell culture supernatants was poorly documented. In this study, a large panel of mycoplasma-contaminated virus stocks (enveloped and non enveloped, RNA and DNA viruses) was tested successfully for mycoplasma removal using two simple optimized methods. These easy-to-perform protocols, using respectively Plasmocin™ (InvivoGen, Cayla, France) and chloroform, were shown to remove mycoplasma completely from cell supernatant without incidence in viral infectivity.


Subject(s)
Culture Media , Decontamination/methods , Mycoplasma/isolation & purification , Animals , Anti-Bacterial Agents/pharmacology , Cell Culture Techniques/methods , Chloroform/pharmacology , France , Macrolides/pharmacology
4.
J Med Virol ; 74(2): 277-82, 2004 Oct.
Article in English | MEDLINE | ID: mdl-15332277

ABSTRACT

The resurgence of Chikungunya virus is described during an urban epidemic in Kinshasa Democratic Republic of the Congo, after 39 years without any isolation of the virus. Chikungunya virus was isolated in sera from nine patients with clinical symptoms. A 1,200 bp long partial sequence of the E1/3'UTR genomic region was determined for each isolate. All sequences clustered in the central African lineage. They constitute Chikungunya virus reference sequences for the Democratic Republic of the Congo.


Subject(s)
Alphavirus Infections/epidemiology , Communicable Diseases, Emerging/epidemiology , Disease Outbreaks , Alphavirus Infections/virology , Antibodies, Viral/blood , Chikungunya virus/classification , Chikungunya virus/genetics , Chikungunya virus/immunology , Chikungunya virus/isolation & purification , Communicable Diseases, Emerging/virology , Democratic Republic of the Congo/epidemiology , Humans , Malaria, Falciparum/complications , Molecular Epidemiology , Molecular Sequence Data , Phylogeny , Sequence Analysis, DNA
5.
Virology ; 315(2): 381-8, 2003 Oct 25.
Article in English | MEDLINE | ID: mdl-14585341

ABSTRACT

Little is known about the genetic relationships between European and other Old-World strains of West Nile virus (WNV) and persistence of WNV North of Mediterranean. We characterized the complete genomes of three WNV strains from France (horse-2000), Tunisia (human-1997) and Kenya (mosquito-1998), and the envelope, NS3 and NS5 genes of the Koutango virus. Phylogenetic analyses including all available full-length sequences showed that: (1) Koutango virus is a distant variant of WNV; (2) the three characterized strains belong to lineage 1, clade 1a; (3) the Tunisian strain roots the lineage of viruses introduced in North America. We established that currently available partial envelope sequences do not generate reliable phylogenies. Accordingly, establishing a large WNV sequence database is pivotal for the understanding of spatial and temporal epidemiology of this virus. For rapid completion of that purpose, colinearized E-NS3-NS5 gene sequences were shown to constitute a valuable surrogate for complete sequences.


Subject(s)
West Nile virus/classification , Africa , Base Sequence , Biological Evolution , Europe , Genes, Viral , Middle East , RNA Helicases , Serine Endopeptidases , Viral Envelope Proteins/genetics , Viral Nonstructural Proteins/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...